Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06979752

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

Led by Hôpital Privé de la Baie · Updated on 2026-02-06

58

Participants Needed

3

Research Sites

191 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Pseudoexfoliative glaucoma is a glaucoma secondary to pseudoexfoliative syndrome; cataract surgery is often more difficult, with more complications. Tran's cannula is a single-use irrigation system designed for cleaning, with the pseudoexfoliative material remaining in the trabecular meshwork. The main objective of this study is to evaluate the efficacy of the Tran cannula, in comparison with increased irrigation, in lowering intraocular pressure (IOP) in patients with pseudoexfoliative glaucoma and treated for glaucoma, and with an indication for isolated cataract surgery.

CONDITIONS

Official Title

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with cataract and early-to-moderate pseudoexfoliative glaucoma scheduled for isolated cataract surgery
  • Reliable visual field test with typical glaucoma changes and mean deviation 3 dB or less
  • Optical coherence tomography showing glaucoma-related ganglion cell and fiber changes
  • Typical glaucomatous optic nerve damage
  • Slit-lamp signs of pseudoexfoliation
  • Open angle (2 to 4 by Shaffer classification) confirmed by gonioscopy
  • Untreated eye pressure above 21 mmHg and below 33 mmHg
Not Eligible

You will not qualify if you...

  • Other eye diseases except cataract or mild dry eye
  • History of intraocular surgery or eye trauma in the last 12 months
  • History of laser trabeculoplasty in the last 12 months
  • Visual acuity worse than finger counting
  • Myopia of 6 diopters or more, hyperopia of 5 diopters or more
  • Iridocorneal angle closure or non-pseudoexfoliative glaucoma types
  • Iris neovascularization
  • Corneal thickness below 490 bc or above 620 bc, or corneal conditions preventing accurate eye pressure measurement
  • Severe systemic diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Hôpital Privé de la Baie

Avranches, France

Actively Recruiting

2

Fondation Rothschild

Paris, France

Actively Recruiting

3

Clinique de la Côte d'Emeraude

St-Malo, France, 35400

Not Yet Recruiting

Loading map...

Research Team

A

Ana Miguel, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here